Paul A. Friedman, Chief Executive Officer at MADRIGAL PHARMACEUTICALS, INC. (MDGL), bought 4,000 shares at $124.00 ($496K) on 2018-11-19, disclosed to the SEC on 2018-11-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| MDGL | SELL | 2025-12-12 | $26.5M | — | Filing → |
| MDGL | SELL | 2025-08-13 | $95.1M | — | Filing → |
| MDGL | SELL | 2025-08-13 | $30.6M | — | Filing → |